Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB1635 Compare Versions

OldNewDifferences
11
22
3-SB1635 HFLR Page 1
4-BOLD FACE denotes Committee Amendments. 1
3+ENGR. S. B. NO. 1635 Page 1 1
54 2
65 3
76 4
87 5
98 6
109 7
1110 8
1211 9
1312 10
1413 11
1514 12
1615 13
1716 14
1817 15
1918 16
2019 17
2120 18
2221 19
2322 20
2423 21
2524 22
2625 23
2726 24
2827
29-HOUSE OF REPRESENTATIVES - FLOOR VERSION
30-
31-STATE OF OKLAHOMA
32-
33-2nd Session of the 58th Legislature (2022)
34-
3528 ENGROSSED SENATE
3629 BILL NO. 1635 By: Jett and Stephens of the
3730 Senate
3831
3932 and
4033
4134 McEntire of the House
42-
43-
4435
4536
4637
4738 An Act relating to pharmacy benefits managers;
4839 amending 36 O.S. 2021, Sections 6960 and 6962, which
4940 relate to definitions and compliance review;
5041 modifying definitions; prohibiting certain actions by
5142 pharmacy benefits managers; providing enforcement
5243 measures for certain violations of the Patient ’s
5344 Right to Pharmacy Choice Act; directing deposit of
5445 certain attorney fees; updating statutory language;
5546 providing for codification; and providing an
5647 effective date.
5748
5849
5950
6051
6152 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
6253 SECTION 1. AMENDATORY 36 O.S. 2021, Section 6960, is
6354 amended to read as follows:
6455 Section 6960. For purposes of the Patient’s Right to Pharmacy
6556 Choice Act:
6657 1. “Clawback” means an act by the pharmacy benefits manager
6758 (PBM) of recovering from the dispensing pharmac y and keeping as
6859 revenue the difference between a patient’s co-payment and the
60+pharmacy drug cost when the co-payment exceeds the pharmacy drug
61+cost;
6962
70-SB1635 HFLR Page 2
71-BOLD FACE denotes Committee Amendments. 1
63+ENGR. S. B. NO. 1635 Page 2 1
7264 2
7365 3
7466 4
7567 5
7668 6
7769 7
7870 8
7971 9
8072 10
8173 11
8274 12
8375 13
8476 14
8577 15
8678 16
8779 17
8880 18
8981 19
9082 20
9183 21
9284 22
9385 23
9486 24
9587
96-pharmacy drug cost when the co-payment exceeds the pharmacy drug
97-cost;
9888 1. 2. “Health insurer” means any corporation, association,
9989 benefit society, exchange, partnership or individual licensed by the
10090 Oklahoma Insurance Code;
10191 2. 3. “Mail-order pharmacy” means a pharmacy licensed by this
10292 state that primarily dispen ses and delivers covered drugs via common
10393 carrier;
10494 3. 4. “Pharmacy benefits manager ” or “PBM” means a person that
10595 performs pharmacy benefits management and any other person acting
10696 for such person under a contractu al or employment relationship in
10797 the performance of pharmacy benefits management for a mana ged-care
10898 company, nonprofit hospital, medical service organization, insuranc e
10999 company, third-party payor or a health program administered by a
110100 department of this sta te;
111101 4. 5. “Pharmacy and therapeutics commit tee” or “P&T committee”
112102 means a committee at a h ospital or a health insurance plan that
113103 decides which drugs will appear on that entity’s drug formulary;
114104 5. 6. “Retail pharmacy network” means retail pharmacy providers
115105 contracted with a PBM in which the phar macy primarily fills and
116106 sells prescriptions via a retail, storefront location;
117107 6. 7. “Rural service area” means a five-digit ZIP code in which
118108 the population density is less than one thousand (1,000) individuals
119109 per square mile;
120110
121-SB1635 HFLR Page 3
122-BOLD FACE denotes Committee Amendments. 1
111+ENGR. S. B. NO. 1635 Page 3 1
123112 2
124113 3
125114 4
126115 5
127116 6
128117 7
129118 8
130119 9
131120 10
132121 11
133122 12
134123 13
135124 14
136125 15
137126 16
138127 17
139128 18
140129 19
141130 20
142131 21
143132 22
144133 23
145134 24
146135
147136 7. 8. “Suburban service area” means a five-digit ZIP code in
148137 which the population density is between one thousand (1,000) and
149138 three thousand (3,00 0) individuals per square mile; and
150139 8. 9. “Urban service area” means a five-digit ZIP code in which
151140 the population density is greater th an three thousand (3,000)
152141 individuals per square mile.
153142 SECTION 2. AMENDATORY 36 O.S. 2021, Section 6962, is
154143 amended to read as follows:
155144 Section 6962. A. The Oklahoma Insurance Depart ment shall
156145 review and approve retail pharmacy network access for all pharmacy
157146 benefits managers (PBMs) to ensure compliance with Section 4 of this
158147 act Section 6961 et seq. of this title.
159148 B. A PBM, or an agent of a PBM, shall not:
160149 1. Cause or knowingly pe rmit the use of advertisement,
161150 promotion, solicitation, representation, proposal or offer that is
162151 untrue, deceptive or misleading;
163152 2. Charge a pharmacist or pharmacy a fee related to the
164153 adjudication or submission of a claim, including without limitation
165154 a fee for:
166155 a. the submission of a claim,
167156 b. enrollment or particip ation in a retail pharmacy
168157 network, or
169158
170-SB1635 HFLR Page 4
171-BOLD FACE denotes Committee Amendments. 1
159+ENGR. S. B. NO. 1635 Page 4 1
172160 2
173161 3
174162 4
175163 5
176164 6
177165 7
178166 8
179167 9
180168 10
181169 11
182170 12
183171 13
184172 14
185173 15
186174 16
187175 17
188176 18
189177 19
190178 20
191179 21
192180 22
193181 23
194182 24
195183
196184 c. the development or management of claims processing
197185 services or claims payment service s related to
198186 participation in a retail pharmacy network;
199187 3. Charge a pharmacist or pharmacy a fee related to the
200188 credentialing of a p harmacy or pharmacist;
201189 4. Charge a pharmacist or pharmacy a fee related to the
202190 application, enrollment, or participation in a retail pharmacy
203191 network;
204192 5. Charge a pharmacist or pharma cy a fee related to the
205193 development or management of claims processing s ervices or claims
206194 payment services related to participation in a retail pharmacy
207195 network;
208196 6. Reimburse a pharmacy or pharmacist in the state an amount
209197 less than the amount that the PBM reimburses a pharmacy owned by or
210198 under common ownership with a PBM for providing the same covered
211199 services. The reimbursement amount paid to the phar macy shall be
212200 equal to the reimbursement amount calculated on a per-unit basis
213201 using the same generic product identifier or generic code number
214202 paid to the PBM-owned or PBM-affiliated pharmacy;
215203 4. 7. Deny a pharmacy the opportunity to participate in any
216204 pharmacy network at preferred participation status if the pharmacy
217205 is willing to accept the terms and conditions that the PBM has
218206 established for other pharmacies as a condition of preferred network
219207 participation status;
220208
221-SB1635 HFLR Page 5
222-BOLD FACE denotes Committee Amendments. 1
209+ENGR. S. B. NO. 1635 Page 5 1
223210 2
224211 3
225212 4
226213 5
227214 6
228215 7
229216 8
230217 9
231218 10
232219 11
233220 12
234221 13
235222 14
236223 15
237224 16
238225 17
239226 18
240227 19
241228 20
242229 21
243230 22
244231 23
245232 24
246233
247234 5. 8. Deny, limit or terminate a pharmacy ’s contract based on
248235 employment status of any employee who has an active license to
249236 dispense, despite probation status, with the State Bo ard of
250237 Pharmacy;
251238 6. 9. Retroactively deny or reduce reimbursement for a covered
252239 service claim after returning a paid clai m response as part of the
253240 adjudication of the claim, unless:
254241 a. the original claim was submitted fraudulently, or
255242 b. to correct errors id entified in an audit, so long as
256243 the audit was conducted in compliance with Sections
257244 356.2 and 356.3 of Title 59 of the Oklahoma Statutes;
258245 or
259246 7. 10. Fail to make any payment due to a pharmacy or pharmaci st
260247 for covered services properly rendered in the event a PBM terminates
261248 a pharmacy or pharmacist from a pharmacy benefits manager network ;
262249 or
263250 11. Participate in a clawback as defined in Section 1 of this
264251 act.
265252 C. The prohibitions under this section shall apply to contracts
266253 between pharmacy benefits managers and pharmacists or pharmacies for
267254 participation in retail pharmacy networks.
268255 1. A PBM contract shall:
269256 a. not restrict, directly or indirectly, any pha rmacy
270257 that dispenses a prescription drug from informing, or
271258
272-SB1635 HFLR Page 6
273-BOLD FACE denotes Committee Amendments. 1
259+ENGR. S. B. NO. 1635 Page 6 1
274260 2
275261 3
276262 4
277263 5
278264 6
279265 7
280266 8
281267 9
282268 10
283269 11
284270 12
285271 13
286272 14
287273 15
288274 16
289275 17
290276 18
291277 19
292278 20
293279 21
294280 22
295281 23
296282 24
297283
298284 penalize such pharmacy for informing, an individual of
299285 any differential between the ind ividual’s out-of-
300286 pocket cost or coverage with re spect to acquisition of
301287 the drug and the amount an individual would pay to
302288 purchase the drug directly, and
303289 b. ensure that any entity that provides pharmacy benefits
304290 management services under a contract with a ny such
305291 health plan or health insurance coverage does not,
306292 with respect to such plan or coverage, restrict,
307293 directly or indirectly, a pharmacy that dispenses a
308294 prescription drug from informing, or penalize such
309295 pharmacy for informing, a covered individual of any
310296 differential between the individual’s out-of-pocket
311297 cost under the plan or coverage with respect to
312298 acquisition of the drug and the amount an individual
313299 would pay for acquisition of the drug without using
314300 any health plan or health insurance coverage , and
315301 c. ensure that access to local healthca re is not
316302 jeopardized by immediately modifying any rates or
317303 provisions that would result in a reimbursement below
318304 the pharmacy’s cost to acquire and dispense the
319305 medication or product .
320306 2. A pharmacy benefits manager’s contract with a participating
321307 pharmacist or pharmacy shall not prohibit, restrict or limit
322308
323-SB1635 HFLR Page 7
324-BOLD FACE denotes Committee Amendments. 1
309+ENGR. S. B. NO. 1635 Page 7 1
325310 2
326311 3
327312 4
328313 5
329314 6
330315 7
331316 8
332317 9
333318 10
334319 11
335320 12
336321 13
337322 14
338323 15
339324 16
340325 17
341326 18
342327 19
343328 20
344329 21
345330 22
346331 23
347332 24
348333
349334 disclosure of information to the Insurance Commissioner, law
350335 enforcement or state and federal governmental officials
351336 investigating or examining a complaint or conducting a revie w of a
352337 pharmacy benefits manager’s compliance with the requir ements under
353338 the Patient’s Right to Pharmacy Choice Act.
354339 3. A pharmacy benefits manager shall establish and maintain an
355340 electronic claim inquiry p rocessing system using the National
356341 Council for Prescription Drug Programs’ current standards to
357342 communicate information to pharmacies submit ting claim inquiries.
358343 SECTION 3. NEW LAW A new section of law to be codified
359344 in the Oklahoma Statutes as Section 6966.1 of Title 36, unless there
360345 is created a duplication in numbering, reads as follows:
361346 A. Notwithstanding any other provisions of law, the Insurance
362347 Commissioner, upon finding a pharmacy benefits manager in violat ion
363348 of Section 6962 of Title 36 of the Oklahoma Statu tes, shall issue a
364349 cease and desist order to the PBM directing it to stop the unlawful
365350 practice. If the PBM fails or refuses to comply with the order, the
366351 Commissioner shall have the authority to revoke or suspend the PBM’s
367352 license. The Commissioner shall use his or her authority to the
368353 extent necessary to obtain the PBM’s compliance with the order. If
369354 requested by the Commissioner, the Att orney General shall offer his
370355 or her assistance to enforce the order of the Commissioner.
371356 B. Reasonable attorney fees shall be awarded the Commissioner
372357 if judicial action is necessary for the enforcement of the order.
373358
374-SB1635 HFLR Page 8
375-BOLD FACE denotes Committee Amendments. 1
359+ENGR. S. B. NO. 1635 Page 8 1
376360 2
377361 3
378362 4
379363 5
380364 6
381365 7
382366 8
383367 9
384368 10
385369 11
386370 12
387371 13
388372 14
389373 15
390374 16
391375 17
392376 18
393377 19
394378 20
395379 21
396380 22
397381 23
398382 24
399383
400384 Fees collected by the Commissioner without assistance of the Office
401385 of the Attorney General shall be credited to the Insurance
402386 Commissioner’s Revolving Fund. Fees collected by the Attorney
403387 General shall be credited to the Attorney Gene ral’s Revolving Fund.
404388 SECTION 4. This act shall become effective November 1, 2022.
389+Passed the Senate the 22nd day of March, 2022.
405390
406-COMMITTEE REPORT BY: COMMITTEE ON PUBLIC HEALTH, dated 04/13/2022 -
407-DO PASS.
391+
392+
393+ Presiding Officer of the Senate
394+
395+
396+Passed the House of Representatives the ____ day of __________,
397+2022.
398+
399+
400+
401+ Presiding Officer of the House
402+ of Representatives
403+